Midgard Science

Labs / Cell line development

A

Antiverse

Cardiff, United Kingdom · antiverse.io

Antiverse discovers developable, functional biologics for GPCRs and other challenging targets using an AI-powered antibody discovery platform. It works with partners in biotechnology and pharma from its base in Cardiff, United Kingdom.

They take quote requests by email.

What they offer

  • De novo antibody and nanobody discovery

    Generates antibody and nanobody sequences de novo from target sequence alone, without requiring an existing ligand, binder, or prior campaign data.

  • Generative AI design

    Uses generative AI to design biologics from target sequence alone and explore novel chemical space, sequence, or structure-based designs.

  • Native membrane screening

    Pans candidates against target receptors expressed in precisely engineered cell lines in their native membrane environment.

  • Functional validation

    Runs cell-based functional assays to confirm agonist, antagonist, or modulator activity against disease-relevant receptors.

  • Developability triage

    Clusters binders by epitope and developability properties to return a diverse, developable panel.

  • AI and ML-guided binder discovery

    Uses proprietary AI and ML models to identify high-potential binders for challenging GPCR and transmembrane targets.

What they work on

Modalities
Antibody
Assays and studies
functional assays, cell-based functional assays, native membrane screening, epitope-specific functional prediction
Therapeutic areas
GPCRs, transmembrane targets
Turnaround
1 month
Sites
Cardiff, United Kingdom
Founded
2017

Similar labs. 2TLab, 3C Therapeutics, 64x, AbboMax

Found in a contract services directory. Listing built from antiverse.io. Work here? Claim this listing.